NetworkNewsBreaks – Earth Science Tech, Inc. (ET
Post# of 333
(Total Views: 224)
Posted On: 10/16/2018 4:40:42 PM
NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Announces Partnership for Laboratory Services Related to Hygee Medical Device
Biotechnology company Earth Science Tech, Inc. (OTCQB: ETST) this morning announced its entry into an agreement with Groupe Opmedic Inc. and its Procrea Fertility Laboratories to provide the laboratory services for the detection of sexually transmitted infections (STIs) in women using Hygee, ETST’s proprietary self-sampling medical device. Procrea Fertility offers an advanced range of laboratory testing of cervical cells, including tests for human papillomavirus (HPV), chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). Per the update, the cervical cell samples collected using Hygee are only certified for CT testing, with NG certification expected to follow shortly. “We are excited to be working with partner that has the same vision as we do,” Dr. Michel Aubé, CEO and CSO of ETST, stated in the news release. “We are concerned for the health of all women and the babies they carry when pregnant. The CT test is so essential for infant’s health that the World Health Organization (WHO) encourages all sexually active women between the ages of 15 and 25 to be tested once a year.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Biotechnology company Earth Science Tech, Inc. (OTCQB: ETST) this morning announced its entry into an agreement with Groupe Opmedic Inc. and its Procrea Fertility Laboratories to provide the laboratory services for the detection of sexually transmitted infections (STIs) in women using Hygee, ETST’s proprietary self-sampling medical device. Procrea Fertility offers an advanced range of laboratory testing of cervical cells, including tests for human papillomavirus (HPV), chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). Per the update, the cervical cell samples collected using Hygee are only certified for CT testing, with NG certification expected to follow shortly. “We are excited to be working with partner that has the same vision as we do,” Dr. Michel Aubé, CEO and CSO of ETST, stated in the news release. “We are concerned for the health of all women and the babies they carry when pregnant. The CT test is so essential for infant’s health that the World Health Organization (WHO) encourages all sexually active women between the ages of 15 and 25 to be tested once a year.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)